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Abstract 
The autonomic nervous system plays an important role in the genesis of atrial fibrillation and 
is one of the candidate targets for atrial fibrillation therapy. This review focuses on the role of 
the autonomic nervous system in atrial fibrillation development and discusses the results of 
the ganglionated plexi catheter and surgical ablation in preclinical and clinical studies. The 
heart is innervated by the extrinsic and intrinsic autonomic nervous systems. The intrinsic 
autonomic nervous system consists of multiple ganglionated plexi and axons, which 
innervate the neighboring atrial myocardium and control their electrophysiological properties. 
Abnormal autonomic innervation has been observed in an animal model of atrial fibrillation 
and in humans. Direct recordings of autonomic nerve activity in canine models showed that 
atrial tachyarrhythmia episodes were invariably preceded by intrinsic cardiac autonomic 
nerve activity, thus supporting the importance of intrinsic cardiac autonomic nerve activity as 
the triggers for atrial tachyarrhythmia. Targeting ganglionated plexi with catheter ablation 
improves the outcomes of paroxysmal atrial fibrillation ablation in addition to pulmonary vein 
antrum isolation. Ablation of ganglionated plexi alone without pulmonary vein isolation is also 
useful in controlling paroxysmal atrial fibrillation in some patients. However, surgical 
ganglionated plexi ablation in patients with a large left atrium, persistent atrial fibrillation 
and/or a history of prior catheter ablation does not result in additional benefits. These 
different outcomes suggest that ganglionated plexi ablation is effective in managing patients 
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with paroxysmal atrial fibrillation, but its effects in patients with persistent atrial fibrillation and 
advanced atrial diseases might be limited.   
 
Keywords: atrial fibrillation, ganglionated plexi, autonomic nervous system, catheter 
ablation, surgical ablation, vagus 
1. Introduction 
Atrial fibrillation (AF) is the most common type of sustained arrhythmia in adults. It can cause 
cardiovascular complications such as ischemic stroke, systemic embolism, heart failure, and 
death. The estimated prevalence in the United States is approximately 5.2 million, and it is 
expected to increase up to 12.1 million by the year of 2030.1 Although the prevalence and 
incidence of AF have been lower in Asian countries than in Western countries, its rate is 
rapidly increasing.2 Catheter or surgical ablation is one of the most important strategies for 
treating AF. It disconnects between the triggers within the pulmonary vein (PV) and the left 
atrium (LA) or eliminates the non-PV foci. In addition, ablation of the ganglionated plexi (GP) 
during pulmonary vein antrum isolation (PVAI) could suppress the vagal response and 
contribute to the effectiveness of AF ablation.3 In this review, we focus on the role of the 
autonomic nervous system (ANS) in AF development and discuss the recent results of 
catheter and surgical ablation of the GP in managing patients with AF.  
 
2. Anatomy of the cardiac autonomic nervous system  
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The heart is innervated by the extrinsic and intrinsic ANS and contains more than 14,000 
neurons.4 The extrinsic ANS consists of both sympathetic and parasympathetic components 
that originates from vagal nerves and the paravertebral sympathetic ganglia, such as the 
stellate (cervicothoracic) ganglion. The intrinsic ANS is also very complex. GP are positioned 
mostly within the epicardial fat pad, and are composed of various ganglia and 
interconnecting axons. Ganglia contain 200 to 1000 neurons that innervate neighboring 
cardiac structures, and connect with sympathetic and parasympathetic nerve fibers from the 
extrinsic ANS.4 Most GP are located near the large vessels and posterior surface of the 
atrium, and 50% of all cardiac ganglia are located near the heart hilum, especially on the 
dorsal and dorsolateral surfaces of the LA. Sympathetic nerve activation could induce 
arrhythmias by enhancing calcium entry, storage, and release in the heart.5 Parasympathetic 
nerve activation could reduce the atrial effective refractory period6 and promote development 
of late phase 3 early after depolarization-induced triggered activity in the atria and the PVs.7, 
8 The sinus node is primarily innervated by the right atrial GP, whereas the atrioventricular 
(AV) node is innervated by the inferior vena cava-inferior atrial GP (also known as the 
inferior right or right inferior GP). The four major GP located near the antrum of the PV are 
as follows: superior left GP (located on the roof of the LA, near the medial side of the left 
superior PV); anterior right GP (located anterior to the right superior PV); inferior left GP and 
inferior right GP (located at the inferior aspect of the posterior LA wall, just below the left and 
right inferior PV).9 GP are connected with each other by interconnecting neurons and create 
an extensive and complicated epicardial neural network. The function of GP is to modulate 
the autonomic interactions between the extrinsic and intrinsic ANS, which affects the sinus 
rate, AV conduction, refractoriness, and inducibility of AF.10 Most autonomic nerves are 
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located within 5 mm of the LA and PV junction and in the anterosuperior segments of the 
superior veins and inferior segments of both inferior veins.11 Adrenergic and cholinergic 
nerves are highly co-localized within these areas; therefore, selective ablation of either 
adrenergic nerves or cholinergic nerves is challenging. Considering the close proximity of 
the autonomic nerves with the commonly ablated lesion set for circumferential PVAI, the 
procedure could result in unintentional autonomic denervation within the LA-PV junction.    
 
3. Direct recording of the autonomic nervous system and atrial tachyarrhythmia 
The role of ANS on cardiac arrhythmogenesis was evaluated by direct recording of 
autonomic nerve activity in ambulatory animals12, 13 and in humans.14, 15 There was circadian 
variation in the sympathetic outflow from the canine stellate ganglia. Simultaneous 
sympathovagal discharges often precede paroxysmal atrial tachycardia (AT) events.16 To 
further analyze the relationship between cardiac autonomic nerve activity and atrial 
tachyarrhythmia, intermittent rapid atrial pacing was performed to increase the number of 
episodes of spontaneous atrial tachyarrhythmia before developing persistent AF.17 After 
cryoablation of the stellate ganglion and the superior cardiac branch of the vagus nerve, 
paroxysmal AF and AT were not observed, suggesting a causal relationship between ANS 
and atrial tachyarrhythmia. However, cryoablation could delay, but not prevent, the 
development of sustained AF by rapid atrial pacing, indicating that there could be factors 
other than nerve activity that determined AF maintenance. To determine the role of the 
intrinsic ANS, we directly recorded both extrinsic and intrinsic autonomic nerve activity in an 
ambulatory canine model (Figure 1).18 Multiple episodes of paroxysmal AT and AF were 
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observed before sustained AF developed. Atrial tachyarrhythmia episodes were invariably 
preceded by intrinsic cardiac nerve activity, thus supporting the importance of GP for 
triggering atrial tachyarrhythmia. The development of technology that allows investigators to 
simultaneously and non-invasively record human skin sympathetic nerve activity,19 has 
shown that increased skin and intrinsic cardiac nerve activities were associated with the 
development of paroxysmal atrial tachyarrhythmia episodes in humans.14, 15 These findings 
are consistent with those observed in canine models. 
The correlation between sympathetic and vagal nerve activity is important in the 
maintenance of AF.20 In a majority of dogs, stellate ganglion nerve activity (SGNA) and vagal 
nerve activity (VNA) showed a nonlinear or L-shaped relationship, with a low correlation 
coefficient. However, in a minority of dogs, SGNA and VNA showed an excellent linear 
correlation, indicating frequent synchronous firing between the two. The latter group of dogs 
had more paroxysmal atrial tachyarrhythmia episodes at baseline and shorter pacing 
duration to induce sustained AF compared with the former group of dogs. These results 
could partially explain the inter-individual variations of susceptibility for persistent AF.  
 
4. Neuromodulation of ganglionated plexi 
4.1. Drugs 
Carvedilol, a non-selective beta-blocker, suppresses SGNA, VNA and GP nerve activity.21 
Carvedilol withdrawal may lead to significant rebound of the nerve activity, suggesting the 
chance of adverse events in those who have neural remodeling when the beta-blocker is 
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suddenly discontinued. However, nadolol did not significantly suppress SGNA in ambulatory 
dogs.13 Lidocaine injection into the GP suppresses AF inducibility.22 Oh et al. reported the 
short-term to mid-term effects of botulinum toxin, a cholinergic neurotransmission blocker, on 
AF inducibility in a canine model.23 Botulinum toxin injection in two fat pads suppressed AF 
inducibility at 1 week, but this disappeared at 2 weeks and 3 weeks. In human randomized 
clinical trials, however, botulinum toxin injected in the epicardial fat pads during cardiac 
surgery not only suppressed postoperative AF but also reduced the incidence of AF for at 
least 1-year.24 The prolonged benefit suggest that botulinum might induce GP remodeling. 
 
4.2. Radiofrequency catheter ablation 
Pappone et al. reported that abolition of the vagal response during circumferential PVAI 
could be achieved in one-third of patients, with heart rate variability attenuation up to 3-
months , and resulted in less AF recurrence at 12 months.25 This study supports the idea 
that GP could be used as a target during AF ablation. GP ablation could be performed using 
two methods: the functional approach, which uses selective high-frequency stimulation to 
find the location of the GP, or the anatomical approach, which uses 3D electroanatomical 
mapping to identify the presumed 4 major GPs. High frequency stimulation could induce 
vagal responses, including AV block (>2 seconds), hypotension or prolongation of the R-R 
interval by more than 50% during AF.26 These responses could be used to guide GP 
ablation. Anatomic GP ablation is simpler than the functional approach using high frequency 
stimulation, but there are several limitations. The GP border cannot be clearly defined and 
the efficacy of ablation is judged by only by local electrogram amplitude reduction. There is 
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the possibility of inter-individual differences in the presumed location of GP. Nevertheless, 
selective GP ablation is associated with a higher recurrence of AF compared with anatomic 
GP ablation for patients with paroxysmal AF.27  
  The Table 1 summarizes the clinical studies showing the feasibility and efficacy of GP 
ablation. The comparison between GP ablation only and PVAI was reported in two small 
studies and in one meta-analysis using those two studies.28-30 Both studies used the 
anatomical GP ablation technique. Patients who underwent GP ablation alone showed 
higher early recurrence rates compared with those who underwent ablation with PVAI alone. 
The study population was small, but the inferior results of GP ablation alone were consistent. 
Three studies compared the efficacy of PVAI plus additional GP ablation versus PVAI 
alone.31-33 Scherlag et al. identified GP using high frequency stimulation and the vagal 
response.33 Ablation at those areas abolished the vagal response. PVAI with additional GP 
ablation resulted in better AF-free survival compared with PVAI alone (91 vs. 71%). Katritsis 
et al. compared anatomic GP ablation in addition to PVAI to PVAI alone in paroxysmal AF 
patients (n=67).31 Combined GP ablation and PVAI resulted in better AF-free survival 
compared with PVAI alone. The study was extended to compare the efficacy of ablation 
among three groups of patients with paroxysmal AF (n=242): PVAI alone vs. GP ablation 
alone vs. PVAI with GP ablation.32 Additional anatomic GP ablation with conventional PVAI 
resulted in better AF-free and AT-free survival compared with either PVI or GP ablation 
alone (74% vs. 56% vs. 48%, respectively; p=0.004 by log-rank test). However, it is 
interesting to note that GP ablation alone was associated with a 48% success rate, 
supporting the importance of GP in the generation of paroxysmal AF. Additional GP ablation 
showed beneficial effects during repeated procedure of PVAI in patients who had 
  
 
This article is protected by copyright. All rights reserved. 
9 
 
paroxysmal AF recurrence after PVAI.34 Several observational GP ablation studies without a 
control group reported variable AF-free survival rates of 38–80%.9, 35-38 One study performed 
GP ablation alone exclusively for patients with long-standing persistent AF.36 Although the 
AF-free survival rate was lower (38%) after GP ablation alone, subsequent repeat PVAI 
increased the rate to 60%, suggesting partial efficacy of GP ablation alone for this 
population. A limitation of these studies is that GP are primarily located near the LA-PV 
junction and that it is difficult to selectively ablate the GP without damaging the nearby 
myocardium. Therefore, attempted GP ablation could result in a wider circumferential 
ablation of the LA-PV junction. The latter effects might account for the better outcomes of 
ablation. 
 
4.3. Surgical ablation  
The Cox-Maze III procedure is an effective surgical method for treating AF, but it has not 
been accepted as a stand-alone treatment due to its invasiveness and complexity.39 
Recently, minimally invasive surgery was reported as a reasonable option for patients with 
lone AF based on the benefit of a smaller incision and reduced complications related to 
cardiopulmonary bypass compared with Cox-Maze surgery. This approach could ablate GP 
located in the epicardium more effectively than endocardial catheter ablation. In a canine 
model involving rapid atrial pacing–induced AF, ablation was performed at the superior left 
GP (SLGP) and the Ligament of Marshall (LOM), and the spontaneous occurrence of 
paroxysmal atrial tachyarrhythmia was eliminated.40 SLGP/LOM ablation also induced cell 
death in stellate ganglion, which could be due to the dying back degeneration after axonal 
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damage. An important physiological consequence is the dramatically reduced heart rate 
responses to SGNA both during sinus rhythm and during AF (Figure 2). The latter findings 
suggest that in addition to eliminating the intrinsic cardiac nerve activity, surgical removal of 
the GPs can also reduce the effects of extrinsic cardiac ANS on the heart. 
GP ablation during minimally invasive surgery for AF did not show beneficial effects 
in preventing AF recurrence.41 Studies performing GP ablation reported lower 12-month AF-
free survival rates than those without GP ablation. However, there are several limitations to 
concluding whether GP ablation during minimally invasive surgery had any role in AF 
prevention because the protocol of GP ablation was not standardized, the number of 
patients included in those studies was small, and the follow-up duration was relatively short. 
Recently, Atrial Fibrillation Ablation and Autonomic Modulation via Thoracoscopic Surgery 
(AFACT) trial tested the efficacy of additional GP ablation during thoracoscopic AF surgery 
with a randomized controlled study design.42 All patients with persistent AF underwent 
thoracoscopic PV isolation of additional linear lesions (Dallas lesion set). Two-hundred forty 
patients were randomized to the additional GP ablation group (GP group) or no additional 
ablation group (control group). Four major GP were localized using anatomic landmarks and 
high frequency stimulation. GP ablation eliminated the vagal responses completely, whereas 
87% in control group still exhibited the vagal responses. The GP group did not show a 
statistically significant difference in AF recurrence compared to the control group. However, 
that group of patients had more events of major bleeding and sinus node dysfunction than 
patients without GP ablation. Because previous randomized studies using catheter based 
techniques showed GP ablation is beneficial in AF control, the negative results of AFACT 
requires some discussion. One possible reason is that Katritsis et al. recruited patients with 
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paroxysmal AF and relatively small LA (size < 50mm). All patients with serious comorbidity 
and previous ablation were excluded. In contrast, most patients in AFACT study had bigger 
LA, persistent AF or previous ablation with recurrence. Only 26 patients (11%) had normal 
LA, and no persistent AF or previous ablation. The AFACT results were in fact similar to that 
observed in preclinical studies using canine models. In the latter studies, cryoablation of the 
stellate ganglion, superior cardiac branch of the vagal nerve, epicardial surgical ablation of 
the GP and vagal nerve stimulation all help reduce or eliminate paroxysmal atrial 
tachyarrhythmias. However, after prolonged pacing, all dogs eventually went into sustained 
AF.17, 20, 40 A second difference of these two studies was the duration of follow-up. The 
AFACT followed up their patients for only 1 year by clinical visits, electrocardiogram and 24-
hour Holter monitoring every 3 months. In comparison, Katritsis et al. followed up the patient 
monthly, and half of the patients had the implantable loop recorder.  
 
5. Limitations of ganglionated plexi ablation 
Catheter or surgical GP ablation could damage various nerve structures, including 
nerves proximal to the GP, the GP itself, or nerves distal to the GP. In addition, ablation 
could also damage the myocardium and other non-neuronal structures, leading to the 
release of neurotrophic factors that promote nerve sprouting.43, 44 The nerve sprouting could 
start as early as 2 hours after injury, and might persist for over 1 month. The patterns of 
reinnervation could be highly heterogeneous, leading to proarrhythmia. A previous study 
showed that partial vagal denervation could facilitate rather than prevent vagally mediated 
AF by increasing the heterogeneity of refractoriness within the atria.45 Mid-term effects (8 
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weeks) of epicardial GP ablation without PVAI showed that it could be proarrhythmic due to 
the decreased atrial effective refractory period and hyper-reinnervation involving both 
sympathetic and parasympathetic nerves.46 Additional GP ablation could create a new 
substrate for the macro-reentry circuit, which could increase the risk of AT. The AFACT trial 
also reported that the GP ablation group more frequently showed AT (as opposed to AF) as 
a clinical recurrence.42 Surgical GP ablation significantly reduces atrial vagal innervation, but 
early reinnervation at 4 weeks was suspected and could explain the nonsustained effect of 
surgical GP ablation.47 In an animal model, the effect of GP ablation on AF inducibility 
disappeared after 4 weeks.48 Finally, the methods of follow-up differed significantly from 
study to study, making it impossible to compare the absolute success rates among studies. 
 
6. Conclusion 
GP comprise an important structure that invariably triggers AF. Targeting GP with catheter 
ablation resulted in better outcomes when combined with conventional PVAI . It is less 
effective than PVAI when GP ablation was performed alone. While GP ablation seems to 
have added benefit to PVAI in patients with paroxysmal AF, surgical GP ablation in patients 
with persistent AF, large LA and previous catheter ablation did not result in additional 
benefits at one year. There are still many questions regarding how to achieve complete GP 
ablation without partial denervation, the best targets and methods for catheter-based GP 
ablation, how to improve the results of surgical GP ablation, how to prevent reinnervation 
and end-organ hypersensitivity and how to select patients for GP ablation. It is clear that 
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more research of this field and novel technologies and strategies are needed before GP 
ablation can be used effectively in managing patients with AF. 
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Figure Legend 
Figure 1. Autonomic nerve activity and paroxysmal AF in a canine model. A shows the 
anatomical location of the Ligament of Marshall (LOM) and superior left ganglionated plexi 
(SLGP). The LOM originates from coronary sinus and connects to left superior PV (LSPV). 
SLGP is located between left atrial appendage (LAA) and LSPV. B, Left stellate ganglion. C, 
Superior cardiac branch of the left vagal nerve. D, An example of paroxysmal atrial 
tachyarrhythmia episode preceded by intrinsic cardiac nerve activity and extrinsic cardiac 
nerve activity. P-wave morphologies during sinus rhythm (Da) and during paroxysmal atrial 
tachycardia (Db) were different in magnified pseudo-ECG. LA, left atrium; LOMNA, ligament 
of Marshall nerve activity; SLGPNA, superior left ganglionated plexi nerve activity; SGNA, 
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stellate ganglion nerve activity; VNA, vagal nerve activity. Reprinted from Choi18 et al. with 
permission. 
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Figure 2. GP and LOM ablation reduces ventricular rate response to SGNA. A, Graph of 
statistical dot plot showing that the SGNA-induced ventricular rate acceleration was 
markedly attenuated by GP ablation compared with the control group. B, An example at 
baseline shows that a burst of SGNA led to ventricular rate increase from 67 to 117 bpm 
(74.6% increment). C, An example after GP ablation shows that a burst of SGNA led to 
ventricular rate increase from 62 to 73 bpm (17.7% increment). Reprinted from Zhao40 et al. 
with permission. 
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Table 1. Catheter ablation of the ganglionated plexi for the treatment of atrial fibrillation. 
 
 Study Ye
ar 
Experim
ent vs. 
control 
group 
Ablatio
n sites 
Study 
design 
Atrial 
fibrillati
on type 
No. 
of 
study 
patie
nts 
Outcomes 
GPA vs 
PVAI 
Katritsis 
DG28 
20
08 
GP vs. 
PVI 
Endocar
dial 
CCS 
Paroxys
mal  
38 
AF 
recurrence: 
74% (GP 
ablation 
group) vs. 
37% (PV 
isolation 
group) 
(log-rank 
test P = 
0.017) 
Mikhaylo
v E29 
20
11 
GP vs. 
PVI 
Endocar
dial 
CCS 
Paroxys
mal  
70 
Freedom 
from any 
atrial 
tachyarrhyt
hmia 
without 
antiarrhyth
mic drugs: 
34.3% (GP 
ablation 
group) vs. 
65.7% (PVI 
group) 
(log-rank 
test P = 
0.008) 
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GPA+P
VAI vs. 
PVAI 
Scherlag 
BJ33 
20
05 
GP + 
PVI vs. 
PVI 
Endocar
dial  
Unknown 
Paroxys
mal  
or 
persiste
nt 
60 
AF-free 
survival: 
91% in GP 
+ PVI 
group vs. 
71% in PVI 
group (no 
statistic 
compariso
n) 
Katritsis 
DG31 
20
11 
GP + 
PVI vs. 
PVI 
Endocar
dial 
RCT 
Paroxys
mal  
67 
Arrhythmia
-free (AF or 
AT) 
survival: 
85.3% in 
PVI + GP 
group vs. 
60.6%  in 
PVI group 
(log rank 
test, P = 
0.019) 
Katritsis 
DG32 
20
13 
GP + 
PVI vs. 
GP vs. 
PVI 
Endocar
dial 
RCT 
Paroxys
mal  
242 
AF-free 
survival: 
74% (GP + 
PVI) vs. 
48% (GP) 
vs. 56% 
(PVI) ( log-
rank test P 
= 0.004) 
Xu FQ34 
20
17 
GP+re-
PVI vs. 
re-PVI 
Endocar
dial 
RCT 
Paroxys
mal 
(recurre
d) 
123 
AF-free 
survival: 
91% (GP + 
re-PVI) vs. 
78% (re-
PVI) (P = 
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0.046) 
GPA 
without 
control 
group) 
Scanava
cca M35 
20
06 
GP 
ablation 
or PVI 
Epicardi
al 
and/or 
endocar
dial  
Observati
onal 
study 
Paroxys
mal  
10 
Recurrenc
e in 5/7 
patients 
who 
underwent 
denervatio
n   
Po SS9 
20
09 
GP + 
PVI 
Endocar
dial 
Observati
onal 
study 
Paroxys
mal  or 
persiste
nt 
80 
Free of 
symptomati
c AF or AT 
after a 
single 
ablation 
procedure: 
80% at 12 
months 
and 86% at 
a mean 
follow-up of 
22 months 
Pokusha
lov E27 
20
09 
Selectiv
e GP vs. 
anatomi
c GP 
ablation 
Endocar
dial 
RCT  
Paroxys
mal  
80 
Free of 
symptomati
c 
paroxysmal 
AF: 42.5% 
in selective 
GP 
ablation vs. 
77.5% in 
anatomic 
GP 
ablation (P 
= 0.02) 
Pokusha
lov E37 
20
10 
Anatomi
c GP 
Endocar
dial 
Observati
onal 
Paroxys
mal  
56 
AF-free 
survival at 
12 months: 
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ablation study 71% 
Pokusha
lov E36 
20
10 
Anatomi
c GP 
ablation 
Endocar
dial 
Observati
onal 
study 
Long 
standing 
persiste
nt 
89 
AF-free 
survival: 
38.2% 
Pokusha
lov E38 
20
12 
GP 
ablation 
guided 
by HFS 
and 
CFAE 
Endocar
dial 
Observati
onal 
study 
Paroxys
mal 
62 
AF-free 
survival at 
12 months: 
71% 
 
AF: atrial fibrillation; AT: atrial tachycardia; CFAE, complex fractionated atrial electrograms; 
CCS: case-controlled study; GP: ganglionated plexi; GPA: GP ablation; HFS, high frequency 
stimulation; PVI: pulmonary vein isolation; PVAI: pulmonary vein antrum isolation; RCT: 
randomized controlled trial; re-PVI: repeated proc nary vein isolation. 
